Table 6.
Relative differences in estimates compared to reference estimates* (ratio) among 32 medicines: by country and managing authority
|
Definition |
Country |
Managing authority |
Level |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
Public |
Non-public |
|
Primary |
Health center |
|
Hospital |
|
||||||||||
| n† | Mean | SE | n† | Mean | SE | p-value‡ | n† | Mean | SE | n† | Mean | SE | p-value‡ | n† | Mean | SE | p-value‡ | ||
| Current availability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
| Reported | |||||||||||||||||||
| |
Kenya |
32 |
1.36 |
0.24 |
32 |
1.02 |
0.01 |
0.17 |
32 |
1.09 |
0.04 |
31 |
1.02 |
0.01 |
0.06 |
32 |
1.01 |
0.00 |
0.04 |
| |
Namibia |
30 |
1.09 |
0.05 |
32 |
1.03 |
0.01 |
0.20 |
30 |
1.08 |
0.03 |
26 |
1.02 |
0.01 |
0.12 |
32 |
1.01 |
0.00 |
0.03 |
| |
Rwanda |
32 |
1.04 |
0.01 |
31 |
1.02 |
0.01 |
0.42 |
26 |
1.03 |
0.01 |
32 |
1.05 |
0.02 |
0.34 |
30 |
1.01 |
0.01 |
0.01 |
| |
Tanzania |
31 |
1.08 |
0.06 |
32 |
1.02 |
0.00 |
0.26 |
31 |
1.07 |
0.04 |
30 |
1.01 |
0.00 |
0.09 |
31 |
1.03 |
0.01 |
0.33 |
| |
Uganda |
30 |
1.04 |
0.02 |
31 |
1.04 |
0.03 |
0.96 |
29 |
1.02 |
0.01 |
30 |
1.04 |
0.01 |
0.21 |
31 |
1.05 |
0.03 |
0.39 |
| Observed, at least one unit regardless of validity | |||||||||||||||||||
| |
Kenya |
32 |
1.35 |
0.24 |
32 |
1.02 |
0.00 |
0.17 |
32 |
1.09 |
0.04 |
31 |
1.00 |
0.00 |
0.04 |
32 |
1.00 |
0.00 |
0.04 |
| |
Namibia |
30 |
1.08 |
0.05 |
32 |
1.02 |
0.01 |
0.19 |
30 |
1.07 |
0.03 |
26 |
1.02 |
0.01 |
0.25 |
32 |
1.00 |
0.00 |
0.06 |
| |
Rwanda |
32 |
1.00 |
0.00 |
31 |
1.01 |
0.00 |
0.26 |
26 |
1.01 |
0.00 |
32 |
1.01 |
0.00 |
0.60 |
30 |
1.00 |
0.00 |
0.03 |
| |
Tanzania |
31 |
1.07 |
0.06 |
32 |
1.01 |
0.00 |
0.27 |
31 |
1.06 |
0.04 |
30 |
1.00 |
0.00 |
0.13 |
31 |
1.01 |
0.01 |
0.22 |
| |
Uganda |
30 |
1.02 |
0.01 |
31 |
1.00 |
0.00 |
0.37 |
29 |
1.01 |
0.01 |
30 |
1.01 |
0.01 |
0.92 |
31 |
1.01 |
0.01 |
0.84 |
| Observed, all units valid | |||||||||||||||||||
| |
Kenya |
32 |
0.87 |
0.05 |
32 |
0.89 |
0.05 |
0.74 |
32 |
0.89 |
0.05 |
31 |
0.91 |
0.04 |
0.78 |
32 |
0.90 |
0.04 |
0.85 |
| |
Namibia |
30 |
0.91 |
0.05 |
32 |
0.92 |
0.04 |
0.91 |
30 |
0.89 |
0.05 |
26 |
0.86 |
0.05 |
0.63 |
32 |
0.92 |
0.04 |
0.69 |
| |
Rwanda |
32 |
0.87 |
0.01 |
31 |
0.83 |
0.02 |
0.19 |
26 |
0.86 |
0.03 |
32 |
0.85 |
0.01 |
0.70 |
30 |
0.88 |
0.01 |
0.36 |
| |
Tanzania |
31 |
0.99 |
0.00 |
32 |
0.98 |
0.00 |
0.60 |
31 |
0.98 |
0.00 |
30 |
0.99 |
0.01 |
0.16 |
31 |
0.99 |
0.00 |
<0.001 |
| |
Uganda |
30 |
0.74 |
0.03 |
31 |
0.87 |
0.02 |
<0.001 |
29 |
0.81 |
0.03 |
30 |
0.78 |
0.04 |
0.55 |
31 |
0.82 |
0.01 |
0.65 |
| Six-month period availability | |||||||||||||||||||
| |
Kenya |
32 |
0.76 |
0.03 |
32 |
0.90 |
0.01 |
0.00 |
32 |
0.86 |
0.01 |
31 |
0.89 |
0.02 |
0.16 |
32 |
0.87 |
0.01 |
0.39 |
| |
Namibia |
30 |
0.94 |
0.02 |
32 |
0.97 |
0.01 |
0.15 |
30 |
0.92 |
0.03 |
26 |
0.93 |
0.02 |
0.70 |
32 |
0.98 |
0.00 |
0.05 |
| |
Rwanda |
32 |
0.85 |
0.03 |
31 |
0.89 |
0.02 |
0.29 |
26 |
0.86 |
0.04 |
32 |
0.87 |
0.03 |
0.88 |
30 |
0.91 |
0.02 |
0.26 |
| |
Tanzania |
31 |
0.80 |
0.04 |
32 |
0.91 |
0.01 |
0.01 |
31 |
0.86 |
0.02 |
30 |
0.87 |
0.02 |
0.81 |
31 |
0.90 |
0.02 |
0.17 |
| Uganda | 30 | 0.70 | 0.03 | 31 | 0.82 | 0.03 | 0.01 | 29 | 0.81 | 0.02 | 30 | 0.74 | 0.03 | 0.09 | 31 | 0.78 | 0.03 | 0.43 | |
SE: standard error.
*Reference value: percent of facilities with at least one valid unit observed on the day of survey.
† n is less than 32, when reference estimates were zero for one or more medicines among the 32.
‡ P-value for t-test of ratio distributions compared public facilities or primary facilities.